Effect of Different HPV Education Methods on Vaccination Intention in Young Women

February 12, 2026 updated by: Emel GÜÇLÜ CİHAN

The Effect of Delivering HPV Education Through Different Methods on Young Women's Intention to Receive the Vaccine: A Randomized Controlled Trial

Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention.

The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years.

The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group.

Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained.

Research Questions

Does HPV education delivered through different methods increase HPV knowledge levels among young women?

Does HPV education increase HPV vaccination intention compared with the control group?

Is face-to-face education more effective than video-based education in increasing vaccination intention?

Are the improvements in knowledge and vaccination intention sustained one month after the education?

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a randomized controlled intervention designed to evaluate the effects of different educational methods on HPV and HPV vaccination knowledge level and vaccination intention among young women aged 18-24 living in the Afşin district of Kahramanmaraş, Türkiye. Participants will be randomly assigned into three groups: control group, video-based education group, and face-to-face education group.

At the beginning of the study, a pre-test will be administered to determine participants' baseline HPV and HPV vaccine knowledge and vaccination intention. Educational interventions prepared in accordance with national health guidelines will be delivered to the intervention groups, while no training will be provided to the control group. Immediately after the education sessions, a post-test will be applied to assess short-term effects, and a follow-up assessment one month later will evaluate the persistence of the effect.

Data will be collected at three time points using an introductory information form, the HPV Knowledge Scale, and the HPV Vaccination Attitude and Intention Form. The findings will be used to compare the effectiveness of different educational methods on HPV knowledge level and vaccination intention.

Study Type

Interventional

Enrollment (Estimated)

117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Kahramanmaraş, Turkey (Türkiye)
        • Recruiting
        • Afşin Aile Sağlığı Merkezleri
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Participants must meet all of the following criteria to be included in the study:

Aged 18-24 years,

Residing in Afşin district, Kahramanmaraş province,

Willing to voluntarily participate in the study,

Literate and able to understand survey questions in Turkish,

Have not previously received the HPV vaccine,

Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),

Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.

Exclusion Criteria:

Participants will be excluded if they meet any of the following conditions:

Under 18 or over 24 years of age,

Have received the HPV vaccine or started the vaccine series,

Have been diagnosed with HPV infection,

Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),

Illiterate or unable to understand the study forms in Turkish,

Withdraw from the study or indicate unwillingness to continue participation,

Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Participants in this group will not receive any HPV education during the study period and will complete the same assessments as the intervention groups at all measurement time points.
Experimental: Video-Based Education Group
Participants in this group will receive HPV and HPV vaccination education delivered through a standardized educational video prepared in accordance with national health guidelines.
Behavioral: Video-Based HPV Education
A structured educational video providing information about HPV infection, transmission, prevention, and HPV vaccination.
Behavioral: Video-Based HPV Education
Participants will receive HPV and HPV vaccination education through a standardized educational video including information about HPV transmission, related diseases, prevention methods, and the benefits of vaccination.
Experimental: Face-to-Face Education Group
Participants in this group will receive HPV and HPV vaccination education through face-to-face training provided by the researcher using standardized educational materials.
Behavioral: Face-to-Face HPV Education
A structured face-to-face educational session conducted by the researcher covering HPV infection, transmission, prevention, and HPV vaccination.
Behavioral: Face-to-Face HPV Education
Participants will receive HPV and HPV vaccination education through a structured face-to-face session conducted by the researcher using standardized educational materials.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HPV Knowledge and Vaccination Intention - Pre-Test
Time Frame: Before education
Young women who consent to participate in the study will complete the Participant Information Form and the HPV Knowledge and Vaccination Intention Scale before receiving any education. This stage aims to determine participants' baseline knowledge and intention to vaccinate.
Before education

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HPV Knowledge and Vaccination Intention - Post-Education Test
Time Frame: Immediately after education
Immediately after the intervention, the experimental groups will receive the designated educational methods (video-based education and face-to-face education), and the same scales will be re-administered. This measurement is intended to evaluate the short-term effect of the education. The control group will not receive any education at this stage, only the assessments will be conducted.
Immediately after education
HPV Knowledge and Vaccination Intention - 1-Month Follow-Up Test
Time Frame: : 1 month after education
One month after the educational intervention, all groups will complete the same scales again to assess the persistence of changes in knowledge and vaccination intention. This measurement evaluates the sustained effect of the educational interventions.
: 1 month after education

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Emel GÜÇLÜ CİHAN

Collaborators

Kahramanmaras Sutcu Imam University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Estimated)

March 31, 2026

Study Registration Dates

First Submitted

February 12, 2026

First Submitted That Met QC Criteria

February 12, 2026

First Posted (Actual)

February 19, 2026

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 12, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HPV-EDU-2026-RCT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the dataset contains sensitive personal information related to participants' health, vaccination intention, and demographic details. To protect participant confidentiality and privacy, access to the data is restricted to the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Human Papillomavirus (HPV) Infection

Clinical Trials on Video-Based HPV Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe